The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1/2 study to evaluate the safety and efficacy of XNW5004, a selective EZH2 inhibitor, in subjects with relapsed/refractory non-Hodgkin lymphoma.
 
Luigui Qiu
No Relationships to Disclose
 
Junyuan Qi
No Relationships to Disclose
 
Weiwei Zheng
No Relationships to Disclose
 
Zhengzi Qian
No Relationships to Disclose
 
Ke-Shu Zhou
No Relationships to Disclose
 
Qingqing Cai
No Relationships to Disclose
 
Kaili Zhong
No Relationships to Disclose
 
Hongmei Jing
No Relationships to Disclose
 
Jianqiu Wu
No Relationships to Disclose
 
Xiaojing Xing
No Relationships to Disclose
 
Yang Cao
No Relationships to Disclose
 
Xi Zhang
No Relationships to Disclose
 
Dongmei Zhou
No Relationships to Disclose
 
Xiaojing Yan
No Relationships to Disclose
 
Zhiye Zhang
No Relationships to Disclose
 
Xinquan Liang
No Relationships to Disclose
 
Liping Su
No Relationships to Disclose
 
Wenjuan Yu
No Relationships to Disclose
 
Hongming He
No Relationships to Disclose